SEC Form 4 · accession 0001645627-18-000053
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Aug 29, 2018
Accepted (ET)
Sep 5, 2018 · 6:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 29, 2018 | P | 1,000 | $0.0418 | A | 25,824,598 | D | |
| Common Stock | Aug 29, 2018 | P | 1,000 | $0.0419 | A | 25,825,598 | D | |
| Common Stock | Aug 29, 2018 | P | 100 | $0.0419 | A | 25,825,698 | D | |
| Common Stock | Aug 29, 2018 | P | 50 | $0.042 | A | 25,825,748 | D | |
| Common Stock | Aug 29, 2018 | P | 950 | $0.042 | A | 25,826,698 | D | |
| Common Stock | Aug 29, 2018 | P | 1,000 | $0.0411 | A | 25,827,698 | D |
Table II — derivative securities
No Table II lines on this filing.